The Patent Finder

Unichem Laboratories Ltd

13 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Aug 6, 2027
    The maintenance fee for Process for the preparation of Rivaroxaban involving novel intermediate (US 11,891,384) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Recombinant Lectin Variants (US 11,965,003) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,118,924Process for the preparation of Apixaban and intermediates thereof
In force
 · USPTO record
In forceUSPTO record
US 10,208,036Process for the preparation of Apixaban and intermediates thereof
In force
 · USPTO record
In forceUSPTO record
US 11,034,683Process for the preparation of rivaroxaban involving novel intermediate
In force
 · USPTO record
In forceUSPTO record
US 11,510,909Pharmaceutical composition of apixaban
In force
 · USPTO record
In forceUSPTO record
US 10,836,730Process for preparation and purification of vortioxetine hydrobromide
In force
 · USPTO record
In forceUSPTO record
US 10,919,855Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4yl]acetamide
In force
 · USPTO record
In forceUSPTO record
US 11,020,390Bioequivalent pharmaceutical composition of vortioxetine hydrobromide
In force
 · USPTO record
In forceUSPTO record
US 11,266,628Pharmaceutical Compositions of Apremilast
In force
 · High confidence
In forceHigh confidence
US 11,891,384Process for the preparation of Rivaroxaban involving novel intermediate
In force
 · USPTO record
In forceUSPTO record
US 11,965,003Recombinant Lectin Variants
In force
 · High confidence
In forceHigh confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 11 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 2 abandoned · 9 no status recorded

Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/828,436Protein for Treatment of Inflammatory DiseasesSep 9, 2024Pending
18/718,862Recombinant Protein for SARS-COV2 DiseaseDec 14, 2022Pending
18/692,059Lectin-Drug ConjugatesSep 30, 2022Pending
18/691,412Recombinant Glycan Binding Proteins and Its UseSep 30, 2022Pending
18/684,064Protein Compositions for the Treatment of Inflammatory DiseasesAug 27, 2022Pending
18/260,404Lectin Protein for Treatment and Prevention of Neurodegenerative DiseasesJan 5, 2022Pending
18/030,583Oct 6, 2021No status recorded
17/923,732Apr 28, 2021No status recorded
17/599,642Mar 28, 2020No status recorded
17/440,124Mar 4, 2020No status recorded
10 of 17 applications shown.
Pro members see all 17 published applications.
Pro members: see all 17 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited